Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 2641 AL 2655

Peptide KED: Molecular-Genetic Aspects of Neurogenesis Regulation in Alzheimer's Disease

Khavinson VK, Lin'kova NS, Umnov RS.

Bull Exp Biol Med. 2021 May;171(2):190-193. doi: 10.1007/s10517-021-05192-6. Epub 2021 Jun 26.

Quantum dots as a theranostic approach in Alzheimer's disease: a systematic review

Villalva MD, Agarwal V, Ulanova M, Sachdev PS, Braidy N.

Nanomedicine (Lond). 2021 Aug;16(18):1595-1611. doi: 10.2217/nnm-2021-0104. Epub 2021 Jun 28.

Efficacy of antidepressant drugs in the treatment of depression in Alzheimer disease patients: A systematic review and network meta-analysis

He Y, Li H, Huang J, Huang S, Bai Y, Li Y, Huang W.

J Psychopharmacol. 2021 Aug;35(8):901-909. doi: 10.1177/02698811211030181. Epub 2021 Jul 9.

The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community

Garibotto V, Albert NL, Barthel H, van Berckel B, Boellaard R, Brendel M, Cecchin D, Ekmekcioglu O, van de Giessen E, Guedj E, Lammerstma AA, Semah F, Traub-Weidinger T, Van Weehaeghe D, Morbelli S; EANM Neuroimaging Committee.

Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3033-3036. doi: 10.1007/s00259-021-05485-y.

Aducanumab: What about the Patient?

Petersen RC.

Ann Neurol. 2021 Sep;90(3):334-335. doi: 10.1002/ana.26181. Epub 2021 Aug 7.

An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study

Sen A, Akinola M, Tai XY, Symmonds M, Davis Jones G, Mura S, Galloway J, Hallam A, Chan JYC, Koychev I, Butler C, Geddes J, Van Der Putt R, Thompson S, Manohar SG, Frangou E, Love S, McShane R, Husain M.

Trials. 2021 Jul 31;22(1):508. doi: 10.1186/s13063-021-05404-4.

High-Definition Transcranial Direct Current Stimulation Improves Delayed Memory in Alzheimer's Disease Patients: A Pilot Study Using Computational Modeling to Optimize Electrode Position

Rasmussen ID, Boayue NM, Mittner M, Bystad M, Grønli OK, Vangberg TR, Csifcsák G, Aslaksen PM.

J Alzheimers Dis. 2021;83(2):753-769. doi: 10.3233/JAD-210378.

Biodanza as a Nonpharmacological Dance Movement-Based Treatment in Older People With Alzheimer's Disease: An Italian Pilot Study in 2 Tuscan Nursing Homes

Chiesi F, Gori E, Collini F, Palfrader A, Galli R, Guazzini A, Collodi S, Lorini C, Bonaccorsi G.

Holist Nurs Pract. 2021 Sep-Oct 01;35(5):264-272. doi: 10.1097/HNP.0000000000000470.

Dosimetry and Clinical Efficacy of Transcranial Photobiomodulation for Major Depression Disorder: Could they Guide Dosimetry for Alzheimer's Disease?

Caldieraro MA, Laufer-Silva T, Cassano P.

J Alzheimers Dis. 2021;83(4):1453-1469. doi: 10.3233/JAD-210586.

Evolution of genetic testing supports precision medicine for caring Alzheimer's disease patients

Bruni AC, Bernardi L, Maletta R.

Curr Opin Pharmacol. 2021 Oct;60:275-280. doi: 10.1016/j.coph.2021.08.004. Epub 2021 Sep 3.

Aducanumab (Aduhelm) for Alzheimer's disease

Med Lett Drugs Ther. 2021 Jul 12;63(1628):105-106.

Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial

Kehoe PG, Turner N, Howden B, Jarutyte L, Clegg SL, Malone IB, Barnes J, Nielsen C, Sudre CH, Wilson A, Thai NJ, Blair PS, Coulthard E, Lane JA, Passmore P, Taylor J, Mutsaerts HJ, Thomas DL, Fox NC, Wilkinson I, Ben-Shlomo Y; RADAR investigators.

Lancet Neurol. 2021 Nov;20(11):895-906. doi: 10.1016/S1474-4422(21)00263-5.

Neuropsychological, neuropsychiatric, and quality-of-life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study

Boada M, López OL, Olazarán J, Núñez L, Pfeffer M, Puente O, Piñol-Ripoll G, Gámez JE, Anaya F, Kiprov D, Alegret M, Grifols C, Barceló M, Bozzo J, Szczepiorkowski ZM, Páez A; AMBAR Trial Group.

Alzheimers Dement. 2022 Jul;18(7):1314-1324. doi: 10.1002/alz.12477. Epub 2021 Nov 2.

[Disease-modifying treatment approaches for Alzheimer's disease]

Frölich L, Hausner L.

Nervenarzt. 2021 Dec;92(12):1239-1248. doi: 10.1007/s00115-021-01222-w. Epub 2021 Nov 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias